Comparable Outcomes Using A CMV-Matched or A Mismatched Donor for CMV Plus Patients Undergoing T-Replete Haplo-HSCT with PT-Cy for Acute Leukemia: A Study from IDWP and ALWP of the EBMT

Abstract

Description

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By